Question 1

What is the catalog number for Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602?

Accepted Answer

The catalog number for Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602 is OV602a.

Question 2

What sizes are available for Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602?

Accepted Answer

Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602 is available in the following size(s): 1 Each.

Question 3

Is Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602 in stock?

Accepted Answer

Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 5

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 6

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores, replacing OV602

Product Specifications

Type

Cases

Cores

Panel Description

Frequently Asked Questions

Explore Other Products

Cytokeratin 7 (Glandular and Transitional Epithelial Marker) (KRT7/2200), CF647 conjugate, 0.1mg/mL

Progesterone (6-5E-3F), CF568 conjugate, 0.1mg/mL

Anti-NSG1 Antibody Picoband®, Dylight550 Conjugate

Fibronectin (Fn-3), CF405S conjugate, 0.1mg/mL

Histone H1 (Nuclear Marker) (r1415-1), CF405S conjugate, 0.1mg/mL

OCT-2 (POU2F2) (B-Cell Marker) (OCT2/2137), CF740 conjugate, 0.1mg/mL